All companies › XRN

XRN · Chiron Real Estate Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

0
Open-market buys
0
Open-market sells
1
INSIDER SCANNER signals
—
Last filing

INSIDER SCANNER signals for XRN

Research signals this company has produced, with the reasoning recorded at the time.

A · HIGH conviction · SWING · 2026-08-10
36.42Entry reference
40.06Model target
30.0Max hold (days)
20.0%Model allocation
Fitzgerald Charles · CEO, Pres, Dir

CEO/President Charles Fitzgerald put in $1.28M on Aug 10, raising his stake 28% — second insider buying alongside, so a real 2-person C-suite cluster. Clean net flow, buy price ($35.94) essentially at current ($36.42), profitable medical REIT with solid FFO of $1.04/share and stable 95%-leased outpatient portfolio; sits 25% off its 52w low, RSI 43, but just below MA20/50 keeps it from A+. Real estate sector is lagging SPY by ~4% and 633M debt vs 10M cash is the main watch-out.

Watch: Sector lagging SPY (-4.4%); high leverage (633M debt vs 11M cash); slightly below MA20/MA50.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.